@RammyaMathew @ArtfulDoctor @DipeshGopal Think important to say urgent referrals are for serious pathology - cancer - but also other serious diagnoses eg IBD, TB etc. demonstrated by RDC data https://t.co/osvLC0ALt2 https://t.co/SabrYLPS2i & likely cos
RT @AskSCHE: @ACRWare @WalesCancerNet @HeatherFWilkes We worked with the Swansea Bay team on economic evaluation. We found their RDC to be…
@ACRWare @WalesCancerNet @HeatherFWilkes We worked with the Swansea Bay team on economic evaluation. We found their RDC to be cost effective https://t.co/luHoHAbpYj
RT @HeatherFWilkes: @ChristmasRowena @rcgp It’s what we found/high pick up rate cancer/other significant pathology, also for cancer - signi…
RT @HeatherFWilkes: @ChristmasRowena @rcgp It’s what we found/high pick up rate cancer/other significant pathology, also for cancer - signi…
RT @HeatherFWilkes: @ChristmasRowena @rcgp It’s what we found/high pick up rate cancer/other significant pathology, also for cancer - signi…
@ChristmasRowena @rcgp It’s what we found/high pick up rate cancer/other significant pathology, also for cancer - significantly quicker & costs less when GP gut instinct is accepted & pt seen in our vague symptom/RD clinic https://t.co/9b8vWhhO0f @
曖昧な症状を有する患者に対するがん早期診断について: 費用対効果の検討 ✔︎ rapid diagnosis centre (RDC) と標準臨床診療とを比較 ✔︎ RDCは平均診断期間を84.2日から5.9日に改善。要精査症例は40.8日。 ✔︎80%以上の出力で実行すると費用対効果に優れる key: RDC https://t.co/6BdRtpdv25
Rapid Diagnosis Centres substantially reduce the time to diagnosis of cancer in patients with vague or non-specific symptoms, and appear to be cost-effective https://t.co/1VURxcD3JD https://t.co/zK6ZyRoYjL
Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study https://t.co/Wd5nuXA28w
Rapid cancer diagnosis for patients with vague symptoms #UK #NHS : a cost-effectiveness study https://t.co/7cYPzkAKgJ
Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study https://t.co/glFNkpDVrC
Very promising results. https://t.co/eqtT5wtoKB
RT @ChrisMResearch: #pancreaticcancer is the 2nd most common cancer to be diagnosed at rapid diagnosis centres. Combine this with these fin…
RT @ChrisMResearch: #pancreaticcancer is the 2nd most common cancer to be diagnosed at rapid diagnosis centres. Combine this with these fin…
Rapid cancer diagnosis for patients with vague symptoms https://t.co/2P8q72brgc
RT @ChrisMResearch: #pancreaticcancer is the 2nd most common cancer to be diagnosed at rapid diagnosis centres. Combine this with these fin…
RT @Katebrain: Important study from Dr Berni Sewell & @SwanseabayNHS showing benefits of Rapid Diagnostic Clinics for people with vague s…
RT @ChrisMResearch: #pancreaticcancer is the 2nd most common cancer to be diagnosed at rapid diagnosis centres. Combine this with these fin…
Yn falch o weld ein gwerthusiad o'r gwasanaeth gwerthfawr hwn yn cael ei gyhoeddi: Diagnosis canser cyflym ar gyfer cleifion â symptomau amhenodol: astudiaeth cost-effeithiolrwydd.
RT @ChrisMResearch: #pancreaticcancer is the 2nd most common cancer to be diagnosed at rapid diagnosis centres. Combine this with these fin…
Important study from Dr Berni Sewell & @SwanseabayNHS showing benefits of Rapid Diagnostic Clinics for people with vague suspected cancer symptoms @WalesCancerNet @theWCRC @tcooper321 https://t.co/8MuWSFNtRW
RT @ChrisMResearch: #pancreaticcancer is the 2nd most common cancer to be diagnosed at rapid diagnosis centres. Combine this with these fin…
RT @VCCLibrary: Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study https://t.co/ZY4PWQxQTx https://t.co/vW…
RT @ChrisMResearch: #pancreaticcancer is the 2nd most common cancer to be diagnosed at rapid diagnosis centres. Combine this with these fin…
RT @ChrisMResearch: #pancreaticcancer is the 2nd most common cancer to be diagnosed at rapid diagnosis centres. Combine this with these fin…
RT @ChrisMResearch: #pancreaticcancer is the 2nd most common cancer to be diagnosed at rapid diagnosis centres. Combine this with these fin…
RT @ChrisMResearch: #pancreaticcancer is the 2nd most common cancer to be diagnosed at rapid diagnosis centres. Combine this with these fin…
RT @ChrisMResearch: #pancreaticcancer is the 2nd most common cancer to be diagnosed at rapid diagnosis centres. Combine this with these fin…
RT @ChrisMResearch: #pancreaticcancer is the 2nd most common cancer to be diagnosed at rapid diagnosis centres. Combine this with these fin…
#pancreaticcancer is the 2nd most common cancer to be diagnosed at rapid diagnosis centres. Combine this with these findings, showing huge improvement in time to diagnosis, you can allow yourself to be legit a little bit buzzing! https://t.co/zhUN0MlzNM
Great to see this fantastic service pilot at NPT Hospital is getting results. https://t.co/0IHxmXa1yb For the full review, by @SwanseaUni see https://t.co/fnVYKdYQ51 now online at British Journal of General Practice
Conclusion | An RDC for patients presenting with vague or non-specific symptoms suspicious of cancer in primary care reduces time to diagnosis and provides excellent value for money if run at ≥80% capacity. | Reported on earlier by the BBC https://t.co/0Q5
RT @drol007: Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study | British Journal of General Practice http…
Rapid #cancer #diagnosis for patients with vague symptoms: a cost-effectiveness study https://t.co/Rm43EyziAj #Research in @BJGPjournal #NHS #research #waittimes
RT @drol007: Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study | British Journal of General Practice http…
Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study | British Journal of General Practice https://t.co/l6tB1siIvE
RT @HeatherFWilkes: it’s a great team effort and definitely impacting on patient care https://t.co/aJElD5FxG1. @MacmillanCymru @cancer_wale…
Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study https://t.co/ZY4PWQxQTx https://t.co/vWu7Rz96H7 #cancer
Delighted to see our evaluation of this valuable service published: Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study https://t.co/qAigCsGyjt
it’s a great team effort and definitely impacting on patient care https://t.co/aJElD5FxG1. @MacmillanCymru @cancer_wales @SwanseabayNHS @SianHarropGriff @RhodDavies1